EMDR Therapy: A Clinical Framework for Trauma-Informed Assessment & Treatment Planning
May 26 @ 2:00 pm – 3:30 pm
1.5 DSM CEs for Social workers, counselors, and nurses
Presenter: Wendi Hogue, M.Ed., LPC, NCC
This continuing education webinar offers mental health clinicians a practical, clinically grounded framework for connecting DSM-5-TR diagnosis to EMDR treatment planning. Participants will examine the trauma related diagnostic categories most encountered in EMDR practice. Including post-traumatic stress disorder, dissociative disorders, major depressive disorder, and anxiety disorders, and consider how each diagnosis points toward specific memory networks and treatment targets.
We will walk through the Adaptive Information Processing (AIP) model and the 8-phase protocol, exploring how theory translates directly into clinical decision-making including where to start, what to target, and how to sequence treatment across complex presentations.
A clinical case example will be used throughout to demonstrate how diagnostic conceptualization becomes an EMDR treatment plan, with specific attention to protocol modifications for dissociation, complex PTSD, and borderline personality disorder.
At the conclusion of this training, participants will be able to:
Discuss contraindications, stabilization strategies, and clinical decision-making for when and how to modify standard EMDR protocols with complex presentations.
Identify the core DSM-5-TR diagnostic categories most associated with trauma presentations and their clinical relevance to EMDR practice.
Explain the theoretical foundations of EMDR therapy, including Shapiro’s Adaptive Information Processing (AIP) model and its neurobiological basis.
Apply EMDR’s 8 phase protocol to clinical case conceptualization across a range of DSM-5-TR diagnoses.
Differentiate EMDR target selection and protocol modifications for PTSD, complex trauma, opioid use disorder, anxiety disorders, depressive disorders, and dissociative presentations, including adaptations for trauma-related symptoms in individuals with comorbid opioid use disorder.